Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The FDA is already under fire from lawmakers for recent delays and rejections of new drugs for rare diseases. on.wsj.com/4b9bef8
https://on.wsj.com/4b9bef8
2026-03-05T23:04:18.662Z